Latest News

Yale Cancer Center joined Hill Day, hosted by the American Association for Cancer Research (AACR) and the Association of American Cancer Institutes (AACI) to bring cancer center directors, researchers, physician-scientists, cancer survivors, and other advocates together to build support for a strong federal investment in biomedical research—and cancer research in particular—through the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Hill Day is a special opportunity in that it helps members of cancer centers secure time to meet with their Congressional representatives to share the importance and impact of cancer funding.

Yale Cancer Center faculty and trainees joined 22,000 cancer researchers from around the world to share the latest advances in cancer science and medicine earlier this week in Chicago for the 116th American Association for Cancer Research (AACR) annual meeting. Dr. Patricia LoRusso, Amy and Joseph Perella Professor of Medicine at Yale Cancer Center and AACR President for 2024-25, shared her global view on cancer. “Cancer is a global disease—it spares no continent, no country. And each patient that gets the disease deserves treatment.”

Yale Cancer Center presentations at the AACR Annual Meeting will include oral and poster presentations as well as educational sessions, showcasing cutting-edge cancer science and medicine.

Formerly called the Conclave Awards, the 2025 Spring Yale Cancer Center awards honored research, clinical expertise, and support staff at the Hotel Marcel, New Haven on April 1, 2025.

Dr. Roy S. Herbst, MD, PhD received the 2024 Ezra Greenspan Award from The Chemotherapy+ Foundation at a gala in New York Nov. 19, 2024. He is a deputy director of the Yale Cancer Center and Chief of Hematology/Medical Oncology, YCC and Smilow Cancer Hospital; Assistant Dean for Translational Research, Yale School of Medicine; Program Director, Master of Health Science—Clinical Investigation Track (MHS-CI)

On November 13, 2024, in honor of Lung Cancer Awareness Month, members of our Center for Thoracic Cancers at Smilow Cancer Hospital presented a patient forum: "Understanding Lung Cancer: A Conference to Raise Awareness and Offer Hope to Those Impacted by Lung Cancer."

Dr. Katerina Politi on Yale Cancer Answers.

A member of the Yale School of Medicine faculty since 2010, Politi co-leads the Cancer Signaling Networks Research Program at the Yale Cancer Center.

The workshop, hosted by Yale Cancer Center and Smilow Cancer Hospital June 12 – 13, was held in commemoration of the 20th anniversary of the discovery of EGFR mutation in lung cancer, which launched the era of personalized medicine in advanced non-small cell lung cancer, leading to a dramatic shift in treatment.